Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Pharmacological Research|January 13, 2017
Pharmacological strategies to target oncogenic KRAS signaling in pancreatic cancerHsiao-Ching Chuang, Po-Hsien Huang, Samuel K Kulp, et al.
Current Pharmaceutical Design|July 18, 2013
AMPK as a potential anticancer target - friend or foe?Hsiao-Ching Chuang, Chih-Chien Chou, Samuel K Kulp, et al.
The Journal of Biological Chemistry|November 2, 2012
The mRNA-stabilizing factor HuR protein is targeted by β-TrCP protein for degradation in response to glycolysis inhibitionPo-Chen Chu, Hsiao-Ching Chuang, Samuel K Kulp, et al.
Molecular and Cellular Biology|September 17, 2005
Stimulation of GCMa transcriptional activity by cyclic AMP/protein kinase A signaling is attributed to CBP-mediated acetylation of GCMaChing-Wen Chang, Hsiao-Ching Chuang, Chenchou Yu, et al.
Nucleic Acids Research|March 11, 2006
Histone deacetylase 3 binds to and regulates the GCMa transcription factorHsiao-Ching Chuang, Ching-Wen Chang, Geen-Dong Chang, et al.
Breast Cancer Research and Treatment|June 9, 2012
Differential anti-proliferative activities of poly(ADP-ribose) polymerase (PARP) inhibitors in triple-negative breast cancer cellsHsiao-Ching Chuang, Naval Kapuriya, Samuel K Kulp, et al.
European Journal of Medicinal Chemistry|September 20, 2017
Targeting breast cancer stem cells by novel HDAC3-selective inhibitorsHao-Yu Hsieh, Hsiao-Ching Chuang, Fang-Hsiu Shen, et al.
Hepatology (Baltimore, Md.)|January 22, 2011
Novel mechanism by which histone deacetylase inhibitors facilitate topoisomerase IIα degradation in hepatocellular carcinoma cellsMei-Chuan Chen, Chun-Han Chen, Hsiao-Ching Chuang, et al.
Pageof 3